REGENXBIO Inc.

RGNX | NASDAQ

Price Alert Chart Builder DCF Calculator

$8.11

+$0.23 (+2.92%)

Sep 22, 2026, 11:27 AM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Net Income	-193.88M	-227.1M	-263.49M	-280.32M	127.84M	-111.25M
Depreciation & Amortization	15.62M	16.22M	17.32M	12.91M	9.56M	8.41M
Stock-Based Compensation	34.56M	38.46M	40.27M	40.79M	38.81M	31.95M
Other Working Capital	21.73M	-3.88M	-12.03M	-9.64M	-899K	2.39M
Other Non-Cash Items	7.96M	-6.23M	-1.61M	5.16M	4.36M	-1.23M
Deferred Income Tax	n/a	n/a	n/a	n/a	-1.92M	3.84M
Change in Working Capital	11.78M	5.53M	-10.89M	13.98M	40.22M	14.22M
Operating Cash Flow	-123.96M	-173.13M	-218.41M	-207.49M	218.88M	-54.06M
Capital Expenditures	-2.41M	-2.44M	-9.96M	-30.72M	-84.18M	-26.87M
Cash Acquisitions	n/a	n/a	n/a	n/a	-4.99M	-149.63M
Purchase of Investments	-332.63M	-190.14M	-86.56M	-184.88M	-498.14M	-123.04M
Sales Maturities Of Investments	319.11M	290.24M	287.47M	203.67M	175.68M	272.67M
Other Investing Acitivies	62K	5.78M	n/a	0	4.99M	149.63M
Investing Cash Flow	-15.87M	103.45M	190.94M	-11.93M	-406.64M	122.76M
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	1.19M	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	115.76M	-39.58M	-41.67M	-30.58M	-22.96M	198.42M
Financial Cash Flow	116.77M	92.68M	-34.97M	-28.84M	195.25M	200.21M
Net Cash Flow	-23.06M	23M	-62.43M	-248.26M	7.48M	268.91M
Free Cash Flow	-126.38M	-175.56M	-228.37M	-238.21M	134.7M	-80.93M
Adj. Free Cash Flow	-160.94M	-214.02M	-268.63M	-279M	95.89M	-112.88M
Maintenance CapEx	n/a	-2.44M	-9.96M	-30.72M	n/a	n/a
Growth CapEx	-2.41M	n/a	n/a	n/a	-84.18M	-26.87M
Owner Earnings	-123.96M	-175.56M	-228.37M	-238.21M	218.88M	-54.06M